This report was recently updated on April 26 2024 with the latest and most recent
market numbers
Global Pharmaceutical B2B Marketplace Market Size, Trends & Analysis - Forecasts to 2029 By Marketplace (Vertical B2B Marketplaces and Horizontal B2B Marketplaces), By Mode of Transaction (Open Marketplace and Private Marketplace), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global pharmaceutical B2B marketplace market is estimated to exhibit a CAGR of 14.6% from 2024 to 2029.
Several factors drive the growth of the global pharmaceutical B2B marketplace market. The increasing demand for pharmaceutical products due to a growing global population and rising prevalence of chronic diseases is a primary driver. This has led to a need for more efficient distribution channels, which B2B marketplaces facilitate by streamlining the supply chain and reducing costs. Also, advancements in technology, particularly in digital platforms, have enabled the creation of more robust and secure B2B e-commerce environments. These platforms enhance transparency, improve order accuracy, and expedite transactions. The globalization of pharmaceutical operations encourages companies to seek cross-border trading opportunities, which B2B marketplaces efficiently support by connecting buyers and sellers from different geographies. Additionally, regulatory changes and the push for cost reductions in healthcare are compelling pharmaceutical companies to adopt B2B marketplaces to remain competitive and compliant. These marketplaces offer a scalable and effective solution to meet these evolving industry needs.
The global pharmaceutical B2B marketplace market faces restraints such as regulatory compliance problems across geographies, risks about data security and privacy, and pushback from established distribution channels. Furthermore, the difficulty of integrating new technology like digital platforms with existing marketplace systems creates major barriers to growth of the market.
On the basis of marketplace, the market is segmented into vertical B2B marketplaces and horizontal B2B marketplaces. The vertical B2B marketplaces segment is expected to be the largest during the forecast period. These platforms specialize in the pharmaceutical sector, catering specifically to the industry's unique needs, such as compliance with stringent regulatory standards and the management of sensitive healthcare data. Their specialization makes them highly attractive to industry participants looking for partners who understand the complexities of pharmaceuticals.
The horizontal B2B marketplaces segment is expected to be the fastest-growing segment in the global pharmaceutical B2B marketplace market over the forecast period. This growth can be attributed to their ability to scale quickly and integrate services across various sectors, providing pharmaceutical companies with access to a broader range of suppliers and buyers, as well as diversified business opportunities. As pharmaceutical companies increasingly seek efficiency and cost-effectiveness, the expansive network and flexibility of horizontal marketplaces could drive their accelerated adoption.
On the basis of mode of transaction, the market is segmented into open marketplace and private marketplace. The open marketplace segment is expected to hold the largest share of the market during the forecast period. This segment benefits from broader accessibility and a larger number of participants, facilitating greater transaction volumes and more diverse product offerings. Open marketplaces attract a wide array of buyers and sellers, making it easier for new entrants and smaller companies to participate, which supports its dominant position.
The private marketplace segment is anticipated to be the fastest-growing in the global pharmaceutical B2B marketplace market during the forecast period. This growth is driven by an increasing demand for more controlled and secure trading environments, especially where high-value, sensitive, or proprietary pharmaceuticals are involved. Private marketplaces offer enhanced data security, regulatory compliance, and tailored customer relationships, appealing to more extensive, established pharmaceutical firms looking for more exclusive and reliable trading conditions.
North America is expected to be the largest region in the global pharmaceutical B2B marketplace market. This is due to its advanced healthcare infrastructure, strong presence of major pharmaceutical companies, and high adoption of digital technologies. The region's stringent regulatory framework also encourages transparency and efficiency in pharmaceutical transactions. Additionally, substantial investments in healthcare IT and a robust demand for pharmaceutical products further drive the adoption of B2B marketplaces in this region.
Asia Pacific is anticipated to be the fastest-growing region in the global pharmaceutical B2B marketplace during the forecast period. The region has observed a rapidly expanding healthcare sector, driven by a large aging population demanding increased medical services. The region's economic growth enhances healthcare spending capabilities, and governments are heavily investing in healthcare infrastructure and digitalization. Additionally, APAC features a significant number of pharmaceutical manufacturing hubs, notably in countries like India and China, which are pivotal in the global supply chain for generic and over-the-counter drugs. The integration of digital platforms in these operations facilitates more efficient B2B transactions. Furthermore, regulatory reforms across the region are encouraging the adoption of digital marketplaces to enhance transparency and efficiency in pharmaceutical procurement and distribution, contributing to the rapid growth of the APAC B2B marketplace market.
eWorldTrade, Medibox, GXgate, Alibaba, Pharma Flair, Made in China, EC21, MedCombo, Amazon Business, and GoApptiv, among others, are some of the key players operating in the global pharmaceutical B2B marketplace market.
Please note: This is not an exhaustive list of companies profiled in the report.
In August 2023, Cairo-based B2B pharmaceutical marketplace Grinta acquired Auto-Cure, a multi-vendor marketplace for Alexandria-based pharmacies. The deal, signed by co-founders Mohamed Azab and Mohamed Rezk, is the third acquisition for Grinta. Auto-Cure, founded in 2022, has processed 5,000 orders for 450 pharmacies since its inception.
In January 2021, Saveo Healthtech, a B2B ecommerce marketplace for pharmacies, raised USD 4 million in its seed funding round from Matrix Partners India and RTP Global. The round included participation from Incubate Fund, India Quotient, and angel investors. Saveo plans to use the funding to expand into new territories and scale up its full-stack tech platform.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
2.4 Data Metrics on Feed Stocks
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL PHARMACEUTICAL B2B MARKETPLACE MARKET, BY MARKETPLACE
4.1 Introduction
4.2 Pharmaceutical B2B Marketplace Market: Marketplace Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Vertical B2B Marketplaces
4.4.1 Vertical B2B Marketplaces Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Horizontal B2B Marketplaces
4.5.1 Horizontal B2B Marketplaces Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL PHARMACEUTICAL B2B MARKETPLACE MARKET, BY MODE OF TRANSACTION
5.1 Introduction
5.2 Pharmaceutical B2B Marketplace Market: Mode of Transaction Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Open Marketplace
5.4.1 Open Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Private Marketplace
5.5.1 Private Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL PHARMACEUTICAL B2B MARKETPLACE MARKET, BY REGION
6.1 Introduction
6.2 North America Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Marketplace
6.2.2 By Mode of Transaction
6.2.3 By Country
6.2.3.1 U.S. Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Marketplace
6.2.3.1.2 By Mode of Transaction
6.2.3.2 Canada Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Marketplace
6.2.3.2.2 By Mode of Transaction
6.2.3.3 Mexico Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Marketplace
6.2.3.3.2 By Mode of Transaction
6.3 Europe Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Marketplace
6.3.2 By Mode of Transaction
6.3.3 By Country
6.3.3.1 Germany Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Marketplace
6.3.3.1.2 By Mode of Transaction
6.3.3.2 U.K. Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Marketplace
6.3.3.2.2 By Mode of Transaction
6.3.3.3 France Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Marketplace
6.3.3.3.2 By Mode of Transaction
6.3.3.4 Italy Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Marketplace
6.3.3.4.2 By Mode of Transaction
6.3.3.5 Spain Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Marketplace
6.3.3.5.2 By Mode of Transaction
6.3.3.6 Netherlands Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Marketplace
6.3.3.6.2 By Mode of Transaction
6.3.3.7 Rest of Europe Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Marketplace
6.3.3.6.2 By Mode of Transaction
6.4 Asia Pacific Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Marketplace
6.4.2 By Mode of Transaction
6.4.3 By Country
6.4.3.1 China Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Marketplace
6.4.3.1.2 By Mode of Transaction
6.4.3.2 Japan Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Marketplace
6.4.3.2.2 By Mode of Transaction
6.4.3.3 India Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Marketplace
6.4.3.3.2 By Mode of Transaction
6.4.3.4 South Korea Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Marketplace
6.4.3.4.2 By Mode of Transaction
6.4.3.5 Singapore Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Marketplace
6.4.3.5.2 By Mode of Transaction
6.4.3.6 Malaysia Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Marketplace
6.4.3.6.2 By Mode of Transaction
6.4.3.7 Thailand Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Marketplace
6.4.3.6.2 By Mode of Transaction
6.4.3.8 Indonesia Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Marketplace
6.4.3.7.2 By Mode of Transaction
6.4.3.9 Vietnam Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Marketplace
6.4.3.8.2 By Mode of Transaction
6.4.3.10 Taiwan Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Marketplace
6.4.3.10.2 By Mode of Transaction
6.4.3.11 Rest of Asia Pacific Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Marketplace
6.4.3.11.2 By Mode of Transaction
6.5 Middle East and Africa Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Marketplace
6.5.2 By Mode of Transaction
6.5.3 By Country
6.5.3.1 Saudi Arabia Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Marketplace
6.5.3.1.2 By Mode of Transaction
6.5.3.2 U.A.E. Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Marketplace
6.5.3.2.2 By Mode of Transaction
6.5.3.3 Israel Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Marketplace
6.5.3.3.2 By Mode of Transaction
6.5.3.4 South Africa Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Marketplace
6.5.3.4.2 By Mode of Transaction
6.5.3.5 Rest of Middle East and Africa Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Marketplace
6.5.3.5.2 By Mode of Transaction
6.6 Central & South America Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Marketplace
6.6.2 By Mode of Transaction
6.6.3 By Country
6.6.3.1 Brazil Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Marketplace
6.6.3.1.2 By Mode of Transaction
6.6.3.2 Argentina Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Marketplace
6.6.3.2.2 By Mode of Transaction
6.6.3.3 Chile Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Marketplace
6.6.3.3.2 By Mode of Transaction
6.6.3.3 Rest of Central & South America Pharmaceutical B2B Marketplace Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Marketplace
6.6.3.3.2 By Mode of Transaction
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 EWorldTrade
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Medibox
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 GXgate
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Alibaba
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 Made in China
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 EC21
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 MedCombo
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Pharma Flair
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Amazon Business
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 GoApptiv
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
2 Vertical B2B Marketplaces Market, By Region, 2021-2029 (USD Million)
3 Horizontal B2B Marketplaces Market, By Region, 2021-2029 (USD Million)
4 Global Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
5 Open Marketplace Market, By Region, 2021-2029 (USD Million)
6 Private Marketplace Market, By Region, 2021-2029 (USD Million)
7 Regional Analysis, 2021-2029 (USD Million)
8 North America Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
9 North America Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
10 North America Pharmaceutical B2B Marketplace Market, By Country, 2021-2029 (USD Million)
11 U.S. Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
12 U.S. Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
13 Canada Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
14 Canada Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
15 Mexico Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
16 Mexico Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
17 Europe Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
18 Europe Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
19 Europe Pharmaceutical B2B Marketplace Market, By Country, 2021-2029 (USD Million)
20 Germany Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
21 Germany Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
22 U.K. Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
23 U.K. Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
24 France Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
25 France Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
26 Italy Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
27 Italy Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
28 Spain Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
29 Spain Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
30 Netherlands Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
31 Netherlands Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
32 Rest Of Europe Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
33 Rest Of Europe Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
34 Asia Pacific Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
35 Asia Pacific Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
36 Asia Pacific Pharmaceutical B2B Marketplace Market, By Country, 2021-2029 (USD Million)
37 China Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
38 China Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
39 Japan Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
40 Japan Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
41 India Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
42 India Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
43 South Korea Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
44 South Korea Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
45 Singapore Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
46 Singapore Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
47 Thailand Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
48 Thailand Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
49 Malaysia Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
50 Malaysia Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
51 Indonesia Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
52 Indonesia Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
53 Vietnam Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
54 Vietnam Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
55 Taiwan Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
56 Taiwan Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
57 Rest of APAC Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
58 Rest of APAC Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
59 Middle East and Africa Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
60 Middle East and Africa Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
61 Middle East and Africa Pharmaceutical B2B Marketplace Market, By Country, 2021-2029 (USD Million)
62 Saudi Arabia Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
63 Saudi Arabia Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
64 UAE Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
65 UAE Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
66 Israel Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
67 Israel Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
68 South Africa Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
69 South Africa Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
70 Rest Of Middle East and Africa Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
71 Rest Of Middle East and Africa Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
72 Central & South America Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
73 Central & South America Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
74 Central & South America Pharmaceutical B2B Marketplace Market, By Country, 2021-2029 (USD Million)
75 Brazil Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
76 Brazil Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
77 Chile Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
78 Chile Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
79 Argentina Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
80 Argentina Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
81 Rest Of Central & South America Pharmaceutical B2B Marketplace Market, By Marketplace, 2021-2029 (USD Million)
82 Rest Of Central & South America Pharmaceutical B2B Marketplace Market, By Mode of Transaction, 2021-2029 (USD Million)
83 EWorldTrade: Products & Services Offering
84 Medibox: Products & Services Offering
85 GXgate: Products & Services Offering
86 Alibaba: Products & Services Offering
87 Made in China: Products & Services Offering
88 EC21: Products & Services Offering
89 MedCombo : Products & Services Offering
90 Pharma Flair: Products & Services Offering
91 Amazon Business, Inc: Products & Services Offering
92 GoApptiv: Products & Services Offering
93 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Pharmaceutical B2B Marketplace Market Overview
2 Global Pharmaceutical B2B Marketplace Market Value From 2021-2029 (USD Million)
3 Global Pharmaceutical B2B Marketplace Market Share, By Marketplace (2023)
4 Global Pharmaceutical B2B Marketplace Market Share, By Mode of Transaction (2023)
5 Global Pharmaceutical B2B Marketplace Market, By Region (Global Market)
6 Technological Trends In Global Pharmaceutical B2B Marketplace Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Pharmaceutical B2B Marketplace Market
10 Impact Of Challenges On The Global Pharmaceutical B2B Marketplace Market
11 Porter’s Five Forces Analysis
12 Global Pharmaceutical B2B Marketplace Market: By Marketplace Scope Key Takeaways
13 Global Pharmaceutical B2B Marketplace Market, By Marketplace Segment: Revenue Growth Analysis
14 Vertical B2B Marketplaces Market, By Region, 2021-2029 (USD Million)
15 Horizontal B2B Marketplaces Market, By Region, 2021-2029 (USD Million)
16 Global Pharmaceutical B2B Marketplace Market: By Mode of Transaction Scope Key Takeaways
17 Global Pharmaceutical B2B Marketplace Market, By Mode of Transaction Segment: Revenue Growth Analysis
18 Open Marketplace Market, By Region, 2021-2029 (USD Million)
19 Private Marketplace Market, By Region, 2021-2029 (USD Million)
20 Regional Segment: Revenue Growth Analysis
21 Global Pharmaceutical B2B Marketplace Market: Regional Analysis
22 North America Pharmaceutical B2B Marketplace Market Overview
23 North America Pharmaceutical B2B Marketplace Market, By Marketplace
24 North America Pharmaceutical B2B Marketplace Market, By Mode of Transaction
25 North America Pharmaceutical B2B Marketplace Market, By Country
26 U.S. Pharmaceutical B2B Marketplace Market, By Marketplace
27 U.S. Pharmaceutical B2B Marketplace Market, By Mode of Transaction
28 Canada Pharmaceutical B2B Marketplace Market, By Marketplace
29 Canada Pharmaceutical B2B Marketplace Market, By Mode of Transaction
30 Mexico Pharmaceutical B2B Marketplace Market, By Marketplace
31 Mexico Pharmaceutical B2B Marketplace Market, By Mode of Transaction
32 Four Quadrant Positioning Matrix
33 Company Market Share Analysis
34 EWorldTrade: Company Snapshot
35 EWorldTrade: SWOT Analysis
36 EWorldTrade: Geographic Presence
37 Medibox: Company Snapshot
38 Medibox: SWOT Analysis
39 Medibox: Geographic Presence
40 GXgate: Company Snapshot
41 GXgate: SWOT Analysis
42 GXgate: Geographic Presence
43 Alibaba: Company Snapshot
44 Alibaba: Swot Analysis
45 Alibaba: Geographic Presence
46 Made in China: Company Snapshot
47 Made in China: SWOT Analysis
48 Made in China: Geographic Presence
49 EC21: Company Snapshot
50 EC21: SWOT Analysis
51 EC21: Geographic Presence
52 MedCombo : Company Snapshot
53 MedCombo : SWOT Analysis
54 MedCombo : Geographic Presence
55 Pharma Flair: Company Snapshot
56 Pharma Flair: SWOT Analysis
57 Pharma Flair: Geographic Presence
58 Amazon Business, Inc.: Company Snapshot
59 Amazon Business, Inc.: SWOT Analysis
60 Amazon Business, Inc.: Geographic Presence
61 GoApptiv: Company Snapshot
62 GoApptiv: SWOT Analysis
63 GoApptiv: Geographic Presence
64 Other Companies: Geographic Presence
65 Other Companies: Company Snapshot
66 Other Companies: SWOT Analysis
The Global Pharmaceutical B2B Marketplace Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Pharmaceutical B2B Marketplace Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
